Mariner’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.26M | Sell |
125,843
-6,098
| -5% | -$203K | ﹤0.01% | 1103 |
|
|
2026
Q1 | $3.97M | Buy |
131,941
+8,141
| +7% | +$262K | ﹤0.01% | 1146 |
|
|
2025
Q4 | $3.86M | Buy |
123,800
+35,149
| +40% | +$866K | ﹤0.01% | 1132 |
|
|
2025
Q3 | $1.79M | Sell |
88,651
-12,129
| -12% | -$213K | ﹤0.01% | 1508 |
|
|
2025
Q2 | $1.69M | Buy |
100,780
+28,012
| +38% | +$452K | ﹤0.01% | 1454 |
|
|
2025
Q1 | $1.12M | Buy |
72,768
+13,412
| +23% | +$240K | ﹤0.01% | 1610 |
|
|
2024
Q4 | $1.31M | Buy |
59,356
+5,689
| +11% | +$103K | ﹤0.01% | 1464 |
|
|
2024
Q3 | $964K | Buy |
53,667
+6,870
| +15% | +$120K | ﹤0.01% | 1634 |
|
|
2024
Q2 | $760K | Sell |
46,797
-1,105
| -2% | -$17K | ﹤0.01% | 1710 |
|
|
2024
Q1 | $676K | Buy |
47,902
+6,456
| +16% | +$81.4K | ﹤0.01% | 1802 |
|
|
2023
Q4 | $433K | Buy |
41,446
+7,223
| +21% | +$67.4K | ﹤0.01% | 2046 |
|
|
2023
Q3 | $349K | Buy |
34,223
+12,274
| +56% | +$114K | ﹤0.01% | 2022 |
|
|
2023
Q2 | $165K | Sell |
21,949
-22,532
| -51% | -$183K | ﹤0.01% | 2524 |
|
|
2023
Q1 | $394K | Buy |
44,481
+10,996
| +33% | +$109K | ﹤0.01% | 1856 |
|
|
2022
Q4 | $306K | Buy |
33,485
+3,103
| +10% | +$27.1K | ﹤0.01% | 2014 |
|
|
2022
Q3 | $245K | Buy |
+30,382
| New | +$269K | ﹤0.01% | 1914 |
|
|
2020
Q4 | – | Sell |
-58,282
| Closed | -$525K | – | 807 |
|
|
2020
Q3 | $525K | Sell |
58,282
-4,048
| -6% | -$42.8K | ﹤0.01% | 606 |
|
|
2020
Q2 | $769K | Sell |
62,330
-2,692
| -4% | -$30.4K | 0.01% | 527 |
|
|
2020
Q1 | $586K | Buy |
65,022
+5,431
| +9% | +$55.6K | 0.01% | 556 |
|
|
2019
Q4 | $584K | Buy |
59,591
+783
| +1% | +$6.99K | 0.01% | 587 |
|
|
2019
Q3 | $405K | Buy |
58,808
+336
| +0.6% | +$2.57K | ﹤0.01% | 619 |
|
|
2019
Q2 | $540K | Buy |
58,472
+8,353
| +17% | +$101K | 0.01% | 700 |
|
|
2019
Q1 | $786K | Buy |
50,119
+69
| +0.1% | +$1.22K | 0.01% | 548 |
|
|
2018
Q4 | $772K | Buy |
50,050
+1,730
| +4% | +$35.5K | 0.01% | 487 |
|
|
2018
Q3 | $1.04M | Sell |
48,320
-1,368
| -3% | -$31.8K | 0.03% | 403 |
|
|
2018
Q2 | $1.21M | Buy |
+49,688
| New | +$1.01M | 0.03% | 366 |
|
|
2017
Q3 | – | Sell |
-9,500
| Closed | -$316K | – | 522 |
|
|
2017
Q2 | $316K | Hold |
9,500
| – | – | 0.01% | 403 |
|
|
2017
Q1 | $305K | Sell |
9,500
-68
| -0.7% | -$2.32K | 0.01% | 457 |
|
|
2016
Q4 | $347K | Sell |
9,568
-322
| -3% | -$12.9K | 0.02% | 421 |
|
|
2016
Q3 | $455K | Sell |
9,890
-2,439
| -20% | -$127K | 0.02% | 384 |
|
|
2016
Q2 | $619K | Buy |
12,329
+7,902
| +178% | +$421K | 0.03% | 300 |
|
|
2016
Q1 | $237K | Buy |
+4,427
| New | +$260K | 0.01% | 441 |
|
|
2015
Q4 | – | Sell |
-12,074
| Closed | -$682K | – | 553 |
|
|
2015
Q3 | $682K | Buy |
12,074
+600
| +5% | +$38.9K | 0.03% | 294 |
|
|
2015
Q2 | $678K | Buy |
+11,474
| New | +$708K | 0.03% | 302 |
|
Other funds holding TEVA
HIIFS
PF
CI
MMH
MIFH
LIM
Mariner's TEVA Position: Q2 2026 in Review
Mariner reduced its Teva Pharmaceuticals (TEVA) stake by 4.6% in Q2 2026, selling an estimated $203K and leaving 125,843 shares worth $4.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1103.
Mariner first reported a position in TEVA in Q2 2015 and has held it in 34 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.
- Mariner held 125,843 shares of Teva Pharmaceuticals worth $4.26M as of Q2 2026.
- Mariner sold 6,098 Teva Pharmaceuticals shares in Q2 2026, an estimated $203K.
- Teva Pharmaceuticals made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1103 holding.
- Mariner first reported a position in Teva Pharmaceuticals in Q2 2015 and has held it in 34 quarters since.
- 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.
Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.